Chiu, W.-J.; Lin, S.-R.; Chen, Y.-H.; Tsai, M.-J.; Leong, M.K.; Weng, C.-F.
Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer. J. Clin. Med. 2018, 7, 321.
https://doi.org/10.3390/jcm7100321
AMA Style
Chiu W-J, Lin S-R, Chen Y-H, Tsai M-J, Leong MK, Weng C-F.
Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer. Journal of Clinical Medicine. 2018; 7(10):321.
https://doi.org/10.3390/jcm7100321
Chicago/Turabian Style
Chiu, Wei-Jun, Shian-Ren Lin, Yu-Hsin Chen, May-Jwan Tsai, Max K. Leong, and Ching-Feng Weng.
2018. "Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer" Journal of Clinical Medicine 7, no. 10: 321.
https://doi.org/10.3390/jcm7100321
APA Style
Chiu, W.-J., Lin, S.-R., Chen, Y.-H., Tsai, M.-J., Leong, M. K., & Weng, C.-F.
(2018). Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer. Journal of Clinical Medicine, 7(10), 321.
https://doi.org/10.3390/jcm7100321